Optimal Heart Failure Medical Therapy and Mortality in Survivors of Cardiogenic Shock: Insights From the FRENSHOCK Registry

Optimal Heart Failure Medical Therapy and Mortality in Survivors of Cardiogenic Shock: Insights From the FRENSHOCK Registry

Background The effects of pharmacological therapy on cardiogenic shock (CS) survivors have not been extensively studied. Thus, this study investigated the association between guideline‐directed heart failure (HF) medical therapy (GDMT) and one‐year survival rate in patients who are post‐CS. Methods...

Full description

Bibliographic Details
Main Authors: Kensuke Matsushita, Clément Delmas, Benjamin Marchandot, François Roubille, Nicolas Lamblin, Guillaume Leurent, Bruno Levy, Meyer Elbaz, Sebastien Champion, Pascal Lim, Francis Schneider, Hadi Khachab, Adrien Carmona, Antonin Trimaille, Jeremy Bourenne, Marie‐France Seronde, Guillaume Schurtz, Brahim Harbaoui, Gerald Vanzetto, Caroline Biendel, Vincent Labbe, Nicolas Combaret, Jacques Mansourati, Emmanuelle Filippi, Julien Maizel, Hamid Merdji, Benoit Lattuca, Edouard Gerbaud, Eric Bonnefoy, Etienne Puymirat, Laurent Bonello, Olivier Morel
Format: Article
Language:English
Published: Wiley 2024-03-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
cardiogenic shock
guideline‐directed medical therapy
heart failure
left ventricular ejection fraction
mortality
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.123.030975

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.123.030975

Similar Items